Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Infosys Limited (INFY) Price & Performance

Amylx Pharmaceuticals IncTrade
Infosys LimitedTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Infosys Limited — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Infosys Limited trades at $12.36 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 19.1× Amylx Pharmaceuticals Inc's market cap, and Infosys Limited pays a 4.16% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXINFY
Market Cap
$2.64B$50.55B
Sector
HealthTechnology
52-Week High
$24.19$20.22
52-Week Low
$7.82$10.49
Enterprise Value
$2.39B$48.30B
Dividend Yield
4.16%

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Infosys Limited

Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.

Read more on INFY